Drug Approvals
🇺🇸 FDA Page 20FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 229–240 of 665 articles
Bristol Myers Unveils Next-Gen Blood Cancer Drug Data
Which Vaccines Will Curb the Ebola Outbreak? WHO Debates
Replimune's Third Attempt at Cancer Drug Approval: Insights from FDA Talks
Allogene CEO Departure and Agios Drug Setback: What It Means for Pharma
Trump Administration's Overhaul of Federal Grantmaking: Impacts on Pharma
Massachusetts Sues UnitedHealth Over Medicaid Fraud Allegations
Modernizing Patient Support in Pharma Amid Rising Young Adult Cancer Rates
Life Sciences Dealmaking Gains Momentum Amid Strategic Pressures
Merck's Cornerstone Cancer Drug at ASCO: Key Insights
Big Pharma's M&A Spree and the March IPO Drought: An Analysis
Pharma M&A Set to Boom in 2026: Market Analysis
Zydus Therapeutics' Saroglitazar Receives FDA Priority Review